These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
804 related articles for article (PubMed ID: 31293340)
1. Effect of NLRC5 on activation and reversion of hepatic stellate cells by regulating the nuclear factor-κB signaling pathway. Zhang YZ; Yao JN; Zhang LF; Wang CF; Zhang XX; Gao B World J Gastroenterol; 2019 Jun; 25(24):3044-3055. PubMed ID: 31293340 [TBL] [Abstract][Full Text] [Related]
2. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis. Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197 [TBL] [Abstract][Full Text] [Related]
3. Role of NLRC5 in progression and reversal of hepatic fibrosis. Liu X; Wu Y; Yang Y; Li W; Huang C; Meng X; Li J Toxicol Appl Pharmacol; 2016 Mar; 294():43-53. PubMed ID: 26806094 [TBL] [Abstract][Full Text] [Related]
4. Calcitriol attenuates liver fibrosis through hepatitis C virus nonstructural protein 3-transactivated protein 1-mediated TGF β1/Smad3 and NF-κB signaling pathways. Shi L; Zhou L; Han M; Zhang Y; Zhang Y; Yuan XX; Lu HP; Wang Y; Yang XL; Liu C; Wang J; Liang P; Liu SA; Liu XJ; Cheng J; Lin SM World J Gastroenterol; 2023 May; 29(18):2798-2817. PubMed ID: 37274069 [TBL] [Abstract][Full Text] [Related]
5. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways. Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168 [TBL] [Abstract][Full Text] [Related]
6. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling. Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890 [TBL] [Abstract][Full Text] [Related]
7. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581 [TBL] [Abstract][Full Text] [Related]
8. Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways. Liu C; Yuan X; Tao L; Cheng Z; Dai X; Sheng X; Xue D BMC Complement Altern Med; 2015 Jun; 15():201. PubMed ID: 26122378 [TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-κB pathway. Feng X; Tan W; Cheng S; Wang H; Ye S; Yu C; He Y; Zeng J; Cen J; Hu J; Zheng R; Zhou Y DNA Cell Biol; 2015 Jul; 34(7):470-80. PubMed ID: 25974152 [TBL] [Abstract][Full Text] [Related]
11. Schisantherin A ameliorates liver fibrosis through TGF-β1mediated activation of TAK1/MAPK and NF-κB pathways in vitro and in vivo. Wang H; Che J; Cui K; Zhuang W; Li H; Sun J; Chen J; Wang C Phytomedicine; 2021 Jul; 88():153609. PubMed ID: 34126414 [TBL] [Abstract][Full Text] [Related]
12. LncRNA MEG3 reverses CCl Wu YY; Wu S; Li XF; Luo S; Wang A; Yin SQ; Huang C; Li J Eur J Pharmacol; 2021 Nov; 911():174462. PubMed ID: 34536366 [TBL] [Abstract][Full Text] [Related]
13. A polysaccharide from Codonopsis pilosula roots attenuates carbon tetrachloride-induced liver fibrosis via modulation of TLR4/NF-κB and TGF-β1/Smad3 signaling pathway. Meng X; Kuang H; Wang Q; Zhang H; Wang D; Kang T Int Immunopharmacol; 2023 Jun; 119():110180. PubMed ID: 37068337 [TBL] [Abstract][Full Text] [Related]
14. Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion. Wu Y; Liu X; Zhou Q; Huang C; Meng X; Xu F; Li J Toxicol Appl Pharmacol; 2015 Dec; 289(2):163-76. PubMed ID: 26435214 [TBL] [Abstract][Full Text] [Related]
15. [Effect of Isodon ternifolius-medicated serum on hepatic stellate cells based on TLR4/NF-κB/NLRP3 signaling pathway]. Huang GD; Zhou ZP; Pang Z; Qin L; Wu RS; Chen Y; Ye XX Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(14):3913-3921. PubMed ID: 37475083 [TBL] [Abstract][Full Text] [Related]
16. LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathway. Yang YR; Bu FT; Yang Y; Li H; Huang C; Meng XM; Zhang L; Lv XW; Li J Mol Immunol; 2020 Oct; 126():31-39. PubMed ID: 32745796 [TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 Scaffolding Domain Peptides Alleviate Liver Fibrosis by Inhibiting TGF-β1/Smad Signaling in Mice. Lu J; Zhang J; Wang Y; Sun Q Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891777 [TBL] [Abstract][Full Text] [Related]
18. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway. Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275 [TBL] [Abstract][Full Text] [Related]
19. New role and molecular mechanism of Gadd45a in hepatic fibrosis. Hong L; Sun QF; Xu TY; Wu YH; Zhang H; Fu RQ; Cai FJ; Zhou QQ; Zhou K; Du QW; Zhang D; Xu S; Ding JG World J Gastroenterol; 2016 Mar; 22(9):2779-88. PubMed ID: 26973416 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-194 inactivates hepatic stellate cells and alleviates liver fibrosis by inhibiting AKT2. Wu JC; Chen R; Luo X; Li ZH; Luo SZ; Xu MY World J Gastroenterol; 2019 Aug; 25(31):4468-4480. PubMed ID: 31496625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]